PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-200

  1. 4,343 Posts.
    lightbulb Created with Sketch. 6888
    Love it

    …so much more to explore with the cytokines Duke…

    The cascading nature needs to be broken… but not eradicated… this is key.

    Down-regulate - yes
    Block - no
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.